dacarbazine and Bone Marrow Neoplasms

dacarbazine has been researched along with Bone Marrow Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ito, M; Ito, R; Kageyama, Y; Katayama, N; Kawakami, K; Masuya, M; Nagaharu, K; Yamaguchi, T	1
Fukuhara, N; Harigae, H; Ichikawa, S; Ichinohasama, R; Katsushima, H; Takahashi, T	1
Deméocq, F; Halle, P; Isfan, F; Kanold, J; Kelly, A; Lang, P; Marabelle, A; Merlin, E; Paillard, C; Rochette, E; Tchirkov, A	1
Leenstra, S; Majoie, CB; Richel, DJ; Terheggen, F; Troost, D	1

Reviews

1 review(s) available for dacarbazine and Bone Marrow Neoplasms

Article	Year
Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature. Journal of medical case reports, 2018, May-30, Volume: 12, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Brentuximab Vedotin; Carboplatin; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Vinblastine	2018

Article

Year

Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.

Journal of medical case reports, 2018, May-30, Volume: 12, Issue:1

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Brentuximab Vedotin; Carboplatin; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Vinblastine

2018

Other Studies

3 other study(ies) available for dacarbazine and Bone Marrow Neoplasms

Article	Year
Advanced Lymphocyte-rich Classical Hodgkin Lymphoma Complicated with Fatal Hemophagocytic Syndrome. Internal medicine (Tokyo, Japan), 2016, Volume: 55, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Neoplasms; Dacarbazine; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Lymphatic Metastasis; Lymphocytes; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Vinblastine	2016
NK cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT. Pediatric blood & cancer, 2012, Volume: 59, Issue:4 Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Bone Marrow Neoplasms; Bone Neoplasms; Child; Combined Modality Therapy; Dacarbazine; Doublecortin Domain Proteins; Haplotypes; Hematopoietic Stem Cell Transplantation; Homeodomain Proteins; Humans; Immunotherapy; Interleukin-2; Killer Cells, Natural; Male; Microtubule-Associated Proteins; Neoplasm, Residual; Neuroblastoma; Neuropeptides; Remission Induction; Temozolomide; Topotecan; Transcription Factors; Transplantation, Homologous; Tyrosine 3-Monooxygenase	2012
Local recurrence and distant metastasis of supratentorial primitive neuro-ectodermal tumor in an adult patient successfully treated with intensive induction chemotherapy and maintenance temozolomide. Journal of neuro-oncology, 2007, Volume: 82, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Liver Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Prednisone; Remission Induction; Supratentorial Neoplasms; Temozolomide; Treatment Outcome; Vincristine	2007